#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Amyotrophic lateral sclerosis gene carrier Cataract Osteochondrodysplasia Dementia with Lewy bodies Vaginal cancer Henoch-Schonlein purpura Short stature homeobox gene mutation Juvenile chronic myelomonocytic leukaemia Fibrous dysplasia of bone Anti-myelin-associated glycoprotein associated polyneuropathy Atypical haemolytic uraemic syndrome Meningitis meningococcal Familial amyotrophic lateral sclerosis Thrombocytosis Biliary cancer metastatic More trials…

    Learn about Rare Diseases

    Urea cycle disorder – Trials in Disease Lysosomal storage disorder – Treatment Leiomyosarcoma – Life with Disease MELAS syndrome – Trials in Disease Stevens-Johnson syndrome – Treatment Malignant fibrous histiocytoma Pulmonary fibrosis Haemophagocytic lymphohistiocytosis – Basic Information Glycogen storage disease type II – Treatment Hereditary hypophosphataemic rickets – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Axitinib 18F-Psma-1007 Zasocitinib Losmapimod Avb-101 Indacaterol Maleate BENZYLPENICILLIN POTASSIUM VERTEPORFIN LUTETIUM LU-177 D-Camphor Palonosetron Hydrochloride IBUZATRELVIR Cobicistat ZUNIBERGENE ROCPARVOVEC Tozorakimab Balcinrenone MALIC ACID Gentamicin Temsirolimus Ecoo2 More therapies…

    Learn about Your Condition

    Frontotemporal dementia Transitional cell carcinoma Dry mouth Renal impairment Postprandial hypoglycaemia Paget's disease of the vulva Vulvar dysplasia Chondroplasty Craniosynostosis Mitochondrial myopathy Malignant melanoma Hydrocele Carcinoid tumour pulmonary Pain Amnestic disorder More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Digestive System Diseases

  • Study Comparing Chemotherapy with Irinotecan, Folinic Acid, and Oxaliplatin for Patients with Locally Recurrent Rectal Cancer

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Rectal cancer recurrent
    Investigated Drugs:
    • Gimeracil
    • Oteracil
    • Tegafur
    Belgium The Netherlands Norway Portugal Sweden

  • Study on ZED1227 for Improving Symptoms in Celiac Disease Patients on a Gluten-Free Diet

    Recruiting

    2 1
    Investigated Diseases:
    • Coeliac disease
    Investigated Drugs:
    • Methyl (E,6S)-7-[[1-[2-(2-Ethylbutylamino)-2-Oxoethyl]-2-Oxopyridin-3-Yl]Amino]-6-[(3-Methylimidazole-4-Carbonyl)Amino]-7-Oxohept-2-Enoate
    Austria Croatia Finland Germany Ireland Italy +5

  • Study on Intermittent vs. Continuous Panitumumab and FOLFIRI for Patients with Unresectable Left-Sided Metastatic Colorectal Cancer

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Colorectal cancer metastatic
    Investigated Drugs:
    • Panitumumab
    Italy

  • Study on Pancreas Removal and Islet Cell Transplant for Patients with Pancreatic Cancer at High Risk of Post-Surgery Leaks

    Recruiting

    2 1 1
    Investigated Diseases:
    • Pancreatic carcinoma
    Investigated Drugs:
    • Autologous Pancreatic Islets
    Germany

  • Study on Botulinum Toxin A Injection for Patients with Large Incisional Hernia

    Recruiting

    3 1 1
    Investigated Diseases:
    • Incisional hernia
    Investigated Drugs:
    • Clostridium Botulinum Neurotoxin Type A (150Kd), Free Of Complexing Proteins
    France

  • Study on the Effectiveness of Infliximab, Ustekinumab, and Vedolizumab for Patients with Resistant Crohn’s Disease

    Recruiting

    2 1 1 1 1
    Investigated Drugs:
    • Vedolizumab
    • Ustekinumab
    • Infliximab
    Poland
Previous Page
1 … 30 31 32 33 34 … 93
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!